glp 1 dos and don ts GLP-1 Meds: What They Really Do What They Don't New Research Reveals the GLP-1
Description
Pradhan R, Yu OHY, Platt RW, Azoulay L
Additional information Publishers Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
As the popularity of Ozempic and Wegovy persists in diabetes and obesity management, ongoing investigations into their side effects, such as gastroparesis, are essential for patient safety
Mol Cell Endocrinol 2001
[DOI] [PMC free article] [PubMed] [Google Scholar] 498.Holz G.G., Leech C.A., Heller R.S., Castonguay M., Habener J.F
